BioSpace News Archive

Moderna is still fending off patent challenges over the lipid nanoparticle delivery system used in its COVID-19 vaccine.

Could big pharma buy out much of the biotech industry? Yes, according to analysts. But that’s not likely to happen anytime soon.

Janssen discontinued the development partnership due to advancements made by other companies against the human papillomavirus and its own changing strategic priorities.

bit.bio announced Monday that it has launched its Huntington’s Disease (HD) cell model to accelerate drug discovery and screening for patients with the disease.

OncoResponse is developing an innovative cancer therapy based upon antibodies produced by patients to components in the tumor microenvironment that regulate the immune response.

Madrigal Pharmaceuticals, Inc. announced acceptance of four abstracts for oral presentation at the European Association for the Study of the Liver’s International Liver Congress, including a late-breaker presentation of data from the Phase 3 MAESTRO-NAFLD-1 trial, as well as other resmetirom clinical development program updates.

Legend Biotech Corporation, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, announced the promotion of Lori Macomber, CPA, to Chief Financial Officer, effective immediately.

Labcorp, a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, announced that they have closed a transaction to expand their long-term strategic relationship.

R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance for healthcare providers, and ScionHealth have entered into an agreement that will make R1 the exclusive provider of revenue cycle management (RCM) services for ScionHealth’s 61 long-term acute care hospitals (LTACHs).

Cano Health, Inc. today announced financial results for the first quarter ended March 31, 2022 .